• 1. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 2. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 3. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592
• 4. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 5. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860

Professional Introduction to 3-(3,4-DIFLUOROPHENYL)ANILINE (CAS No. 866108-75-0)

3-(3,4-DIFLUOROPHENYL)ANILINE, a compound with the chemical identifier CAS No. 866108-75-0, represents a significant advancement in the realm of pharmaceutical and chemical research. This compound, characterized by its unique structural and functional properties, has garnered considerable attention in recent years due to its potential applications in medicinal chemistry and material science. The presence of fluorine atoms in its aromatic ring system imparts distinct electronic and steric effects, making it a valuable scaffold for the development of novel bioactive molecules.

The synthesis of 3-(3,4-DIFLUOROPHENYL)ANILINE involves a series of well-defined chemical transformations that highlight the compound's versatility. The introduction of fluorine substituents at the 3 and 4 positions of the phenyl ring enhances its reactivity and stability, enabling its use in various synthetic pathways. Recent studies have demonstrated that this compound can serve as a precursor for more complex molecules, including pharmacologically active agents and advanced materials. The precision required in its synthesis underscores the importance of understanding its molecular interactions and reactivity patterns.

In the context of pharmaceutical research, 3-(3,4-DIFLUOROPHENYL)ANILINE has been explored for its potential role in drug discovery. Its structural motif is reminiscent of several known bioactive compounds, suggesting that it may exhibit similar pharmacological properties or serve as a lead compound for further derivatization. Researchers have leveraged computational methods to predict the binding affinity of this compound to various biological targets, providing insights into its potential therapeutic applications. These studies have been complemented by experimental investigations, which have validated many of these computational predictions.

The incorporation of fluorine atoms into organic molecules is a well-established strategy to modulate their biological activity. In the case of 3-(3,4-DIFLUOROPHENYL)ANILINE, the electron-withdrawing nature of fluorine influences the electronic distribution within the molecule, thereby affecting its interactions with biological targets. This has led to interest in using this compound as an intermediate in the synthesis of fluorinated drugs, which often exhibit improved metabolic stability and bioavailability. The growing body of literature on fluorinated anilines underscores their significance in modern drug development.

Advances in synthetic methodologies have also contributed to the increasing utility of 3-(3,4-DIFLUOROPHENYL)ANILINE. Modern techniques such as transition metal-catalyzed cross-coupling reactions have made it possible to introduce fluorine substituents with high selectivity and efficiency. These methods have enabled chemists to access a wider range of derivatives with tailored properties, expanding the potential applications of this compound. The ability to fine-tune its structure has opened new avenues for exploration in both academic and industrial research settings.

The impact of 3-(3,4-DIFLUOROPHENYL)ANILINE extends beyond pharmaceuticals into other areas such as materials science. Fluorinated aromatic compounds are known for their unique electronic properties, making them suitable for use in organic electronics and optoelectronic devices. The presence of fluorine atoms can enhance charge transport properties and improve device performance. Researchers are investigating how incorporating this compound into polymer matrices or thin films can lead to novel materials with enhanced functionality.

The environmental and safety considerations associated with handling 3-(3,4-DIFLUOROPHENYL)ANILINE are also important aspects of its application. While it is not classified as a hazardous substance under current regulations, proper handling procedures must be followed to ensure safe laboratory practices. This includes using appropriate personal protective equipment (PPE) and working in well-ventilated areas to minimize exposure risks. As with any chemical substance used in research or industrial settings, adherence to safety protocols is essential.

The future prospects for 3-(3,4-DIFLUOROPHENYL)ANILINE are promising given its versatility and potential applications across multiple disciplines. Ongoing research continues to uncover new synthetic routes and functional derivatives that could further expand its utility. Collaborative efforts between academia and industry are likely to drive innovation in this field, leading to novel applications that could benefit society in significant ways.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)